News | News By Subject | News by Disease News By Date | Search News

Pain control News Articles

Get Our FREE
Industry eNewsletter
email:    
Top Breaking News
First Time Ever: FDA Asks Endo Pharma (ENDP) to Stop Selling Opana ER Amid Opioid Crisis     6/9/2017
This Bay Area Biotech Snags $293 Million Pain Drug Pact With Novartis AG (NVS)     5/9/2017
For Sale: Nektar Therapeutics (NKTR) Plans to License Hot New Opioid Drug     3/21/2017
New Grunenthal CEO Forges Ahead with Treatment for Complex Regional Pain Syndrome     1/18/2017
Innocoll (INNL) Shares Tumble After FDA's Refusal to File Xaracoll NDA     12/30/2016
FDA Slaps Hold on Regeneron (REGN), Teva (TEVA)'s Pain Drug Fasinumab     10/18/2016
Gilead (GILD) Might Avoid Fighting Celgene (CELG), But Allergan (AGN), Intercept Pharma (ICPT) and Novartis AG (NVS) Await     10/4/2016
How Abbott (ABT) and Its Sales Reps Quietly Played a Role in the OxyContin Epidemic     9/22/2016
Teva (TEVA) Forges $2.6 Billion Deal to Buy Into Regeneron (REGN)'s Pain Drug Fasinumab     9/20/2016
Tonix Pharma (TNXP) to Stop Testing Lead Pain Drug, Stock Craters     9/6/2016
AcelRx (ACRX)' ARX-04 Phase 3 Trial Met its Primary Endpoint     8/15/2016
Endo International (ENDP) Withdraws Its Supplemental NDA for Pain Drug OPANA     8/12/2016
Recro Pharma (REPH) Shares Rocket as Intravenous Painkiller Succeeds in Phase III Trial     7/27/2016
What Purdue Pharma L.P. Knew About a Oxycontin Ring that Pushed More than 1 Million Pills     7/11/2016
Unclear Whether FDA Took Into Account KemPharm (KMPH)'s Amendment Data in Rejecting Apadaz Application     6/14/2016

News from Around the Web
Why This Small Biotech With A Single Drug In Human Trials Might Be A Big Winner     6/22/2017
Why This Struggling Socal Biotech Could Be The Next Big Marijuana Stock     5/23/2017
3 Revolutionary Drugs for Chronic Pain     3/31/2017
Senators Question Kaleo Over 680% Price Hike of Naloxone Injector Evzio     2/10/2017
University of Pennsylvania Should Rethink Over-Hyped Press Releases     1/11/2017
Tech Devices To Treat Chronic Pain Could Curb Opioid Use, SPR Therapeutics Reveals     1/6/2017
New Compound May Treat Pain Without Opioid- Or Marijuana-Use Side Effects, Indiana University Study     11/15/2016
PRECISION Results Open The Door For OTC Celebrex     11/15/2016
Can A "Smart" Pain Management System Be Alternative To Opioids For Chronic Pain?     11/4/2016
Specialists Alarmed About Children Prescribed Opium-Derived Painkillers     10/31/2016
"Fake Pills" May Help Ease Back Pain, Beth Israel Deaconess Medical Center Study     10/21/2016
New Opioids Could Relieve Pain Without Dangerous Side Effects, UCSF Study     10/17/2016
Why Does My Pain Come And Go?     10/6/2016
An Opioid Spray Showered Billionaire John Kapoor In Riches. Now He's Feeling The Pain     10/5/2016
Artificial Knee Implant Provides New Treatment Options For Joint Pain     9/30/2016

Press Releases
Braeburn Pharma Release: Phase II Trial Demonstrates Long-acting Buprenorphine Blocks Opioid Effects and Suppresses Withdrawal Symptoms in Adults with Opioid Use Disorder     6/23/2017
Axim Biotech Files Patent On Controlled Release Chewing Gum To Provide Opioid Addiction Treatment     6/23/2017
NeuroMetrix (NURO) Provides Update on Quell Wearable Pain Relief Clinical Program     6/23/2017
Indivior Presents Results From The Phase III Pivotal Study Of RBP-6000 Buprenorphine Monthly Depot For The Treatment Of Opioid Use Disorder     6/22/2017
DURECT (DRRX) Completes Enrollment In PERSIST, Phase III Trial For POSIMIR     6/22/2017
Cara Therapeutics (CARA) Reports Continuation Of Phase III Trial Of I.V. CR845 In Postoperative Pain Following Interim Assessment     6/21/2017
Trevena (TRVN) Attends NIH Meeting To Discuss Development Of Novel, Improved Pain Medications     6/21/2017
Braeburn Pharma And Camurus Announce Presentations Of Pivotal Clinical Study Data Of Long-Acting Buprenorphine     6/15/2017
Centrexion Announces New 6-Month Data Demonstrating Significant And Durable Pain Relief With CNTX-4975 For Treatment Of Moderate To Severe Knee Osteoarthritis Pain     6/14/2017
Zosano (ZSAN) Presents Additional Data From ZOTRIP Study At American Headache Society, Demonstrating Positive Results For Pain Freedom And Sustained Pain Freedom     6/12/2017
ObsEva (OBSV) Announces The Completion Of A Phase I PK/PD Clinical Trial Evaluating Different Doses Of OBE2109 And Add-Back Therapy     6/7/2017
Proove Biosciences Release: 90% Of Patients Achieve 40% Pain Reduction Within 60-Days In Large Precision Medicine Clinical Trial     5/31/2017
Anika Therapeutics (ANIK) Announces Publication Of Phase III Data Demonstrating The Efficacy And Safety Of CINGAL For The Treatment Of Knee Pain Associated With Osteoarthritis     5/22/2017
NYU Langone Medical Center Release: Chronic Pain Amplifies The Brain's Reaction To New Injuries     5/22/2017
NeuroMetrix (NURO) Announces Issuance Of New U.S. Patent For Quell Wearable Pain Relief Technology     5/22/2017

//-->